Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post' - 2Former 'Bachelorette' welcomes 1st baby via emergency c-section
- 3Building an Individual Brand: Illustrations from Powerhouses
- 4Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- 5JFK's granddaughter Tatiana Schlossberg reveals terminal cancer diagnosis
- Unraveling the Specialty of Picking Your Ideal Travel Objective
- Extraordinary Snowboarding Objections All over the Planet
- Underestimated Metropolitan Experience Urban communities On the planet
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Congo declares its latest Ebola outbreak over, after 43 deaths
- Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.
- Evaluated Smartwatches for Wellness Devotees
- Katz alleges Army Radio workers misled High Court in bid to halt closure
- Vote In favor of Your Number one Cell phones
